Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial
Background A quadrivalent split influenza vaccine IIV4-W against both influenza A and B viruses is urgently needed. Methods To evaluate the safety and immunogenicity of IIV4-W in people aged 3-60 years, 2400 participants recruited in a double-blind phase III trial and were randomly assigned to the I...
Saved in:
Main Authors: | Xiaoyuan Huang (Author), Ting Fan (Author), Li Li (Author), Xuanxuan Nian (Author), Jiayou Zhang (Author), Xuefen Gao (Author), Wei Zhao (Author), Wei Chen (Author), Zhaoqing Zhang (Author), Zhihao Yao (Author), Xixin Han (Author), Jinrong Shi (Author), Ying Wang (Author), Haihe Bian (Author), Nianmin Shi (Author), Xinguo Li (Author), Kai Duan (Author), Guohua Li (Author), Xiaoming Yang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season
by: Anne-Laure Chabanon, et al.
Published: (2021) -
Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study
by: Renfeng Fan, et al.
Published: (2022) -
Development of Nasal Vaccines and the Associated Challenges
by: Xuanxuan Nian, et al.
Published: (2022) -
Immunogenicity and safety of the 2015 Southern Hemisphere formulation of a split-virion inactivated quadrivalent vaccine
by: Cecilia Montalban, et al.
Published: (2018) -
Immunogenicity of influenza vaccine in elderly people: a systematic review and meta-analysis of randomized controlled trials, and its association with real-world effectiveness
by: Ziyan Meng, et al.
Published: (2020)